Once-weekly insulin icodec non-inferior to daily insulin degludec in patients with type 1 diabetes
1. Mean HbA1c reduction at 26 weeks was comparable in the weekly icodec and daily degludec groups. 2. The risk ...
Tag: hyperglycemia
Once-weekly tirzepatide significantly improves weight and glycemic control in patients with with obesity and type 2 diabetes
1. Body weight reduction at week 72 was significantly greater with tirzepatide versus placebo. 2. Hemoglobin A1c was significantly reduced ...
Retatrutide associated with improved glycemic control and bodyweight reduction in type 2 diabetes
1. HbA1c and bodyweight reduction were greater in the retatrutide group compared to dulaglutide and placebo. 2. The effect of ...
Orforglipron may be a safe and effective oral GLP-1 agonist for treatment of type 2 diabetes
1. Patients assigned to orforglipron experienced significant reductions in HbA1c, and body weight compared to other groups. 2. The majority ...
Treatment of gestational diabetes before 20 weeks’ gestation improves neonatal outcomes
1. In this randomized controlled trial, the treatment of gestational diabetes before 20 weeks' gestation was associated with a lower ...
Once-weekly insulin icodec non-inferior to daily insulin glargine for patients with type 2 diabetes on basal-bolus regimens
1. At 26 weeks, the mean change in HbA1c was comparable between the weekly insulin icodec and daily glargine U100 ...
High-dose corticosteroids increase morbidity and mortality among hypoxic COVID-19 patients
1. Patients in the high-dose dexamethasone group reported significantly greater mortality within 28 days of treatment. 2. Occurrence of non-COVID-19 ...
#VisualAbstract: Continuous glucose monitoring in type 1 diabetes results in improved blood glucose levels
1. In patients with type 1 diabetes, using intermittently scanned continuous glucose monitoring resulted in significantly lower glycated hemoglobin levels ...
Youth-onset type 2 diabetes may have increased sharply during the COVID-19 pandemic
1. In a retrospective cohort of about 3,000 children and young adults, new diagnoses of type 2 diabetes increased by ...
Tirzepatide improves glycemic control and weight loss in patients with type 2 diabetes
1. Tirzepatide was superior to placebo with regard to changes in HbA1c, serum glucose, body weight loss, and proportion of ...